Iradimed (IRMD) Preferred Shares (2013 - 2014)

Iradimed (IRMD) reported Preferred Shares of $140.0 for Q2 2014, little changed quarter-over-quarter from $140.0 in Q4 2013.

Iradimed (IRMD) Preferred Shares (2013 - 2014) Analysis & Trends

Iradimed (IRMD) has 2 years of Preferred Shares data on file, last reported at $140.0 in Q2 2014.

  • Preferred Shares for Q2 2014 came in at $140.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2014 was $140.0 (changed N/A YoY), and the FY2013 annual result was $140.0, changed N/A from the prior year.
  • Preferred Shares held at $140.0 in Q2 2014 per IRMD's latest filing, from $140.0 in the prior quarter.
  • Over five years, Preferred Shares peaked at $140.0 in Q4 2013 and troughed at $140.0 in Q4 2013.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Iradimed 1.18 Bn 1.12 Bn 16.81 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2014 140.00
Dec 31, 2013 140.00